{"id":"https://openalex.org/W2765520397","doi":"https://doi.org/10.3389/fphar.2017.00779","title":"The Modulatory Properties of Chronic Antidepressant Drugs Treatment on the Brain Chemokine \u2013 Chemokine Receptor Network: A Molecular Study in an Animal Model of Depression","display_name":"The Modulatory Properties of Chronic Antidepressant Drugs Treatment on the Brain Chemokine \u2013 Chemokine Receptor Network: A Molecular Study in an Animal Model of Depression","alternate_titles":[],"publication_year":2017,"publication_date":"2017-11-01","ids":{"openalex":"https://openalex.org/W2765520397","doi":"https://doi.org/10.3389/fphar.2017.00779","mag":"2765520397","pmid":"https://pubmed.ncbi.nlm.nih.gov/29163165","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5671972"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2017.00779","doi":"https://doi.org/10.3389/fphar.2017.00779","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2017.00779","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2017.00779/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2765520397"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2017.00779/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079453042","display_name":"Ewa Trojan","orcid":"https://orcid.org/0000-0002-9573-7026","observed_orcids":["https://orcid.org/0000-0002-9573-7026"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ewa Trojan","raw_affiliation_strings":["Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001248059","display_name":"Joanna \u015alusarczyk","orcid":"https://orcid.org/0009-0008-6405-5963","observed_orcids":["https://orcid.org/0009-0008-6405-5963"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joanna \u015alusarczyk","raw_affiliation_strings":["Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064353591","display_name":"Katarzyna Chamera","orcid":"https://orcid.org/0000-0002-1432-7763","observed_orcids":["https://orcid.org/0000-0002-1432-7763"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Katarzyna Chamera","raw_affiliation_strings":["Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038373788","display_name":"Katarzyna Kotarska","orcid":"https://orcid.org/0000-0003-3235-9475","observed_orcids":["https://orcid.org/0000-0003-3235-9475"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Katarzyna Kotarska","raw_affiliation_strings":["Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025128923","display_name":"Katarzyna G\u0142ombik","orcid":"https://orcid.org/0000-0002-7695-2556","observed_orcids":["https://orcid.org/0000-0002-7695-2556"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Katarzyna G\u0142ombik","raw_affiliation_strings":["Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008912771","display_name":"Marta Kubera","orcid":"https://orcid.org/0000-0003-4401-5055","observed_orcids":["https://orcid.org/0000-0003-4401-5055"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marta Kubera","raw_affiliation_strings":["Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027163504","display_name":"Agnieszka Basta\u2010Kaim","orcid":"https://orcid.org/0000-0002-3109-0040","observed_orcids":["https://orcid.org/0000-0002-3109-0040"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Agnieszka Basta-Kaim","raw_affiliation_strings":["Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5027163504"],"corresponding_institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":1.3893,"has_fulltext":true,"cited_by_count":57,"citation_normalized_percentile":{"value":0.75925926,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"8","issue":null,"first_page":"779","last_page":"779"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.6973000168800354,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.6973000168800354,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.2467000037431717,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.018400000408291817,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.722000002861023},{"id":"https://openalex.org/keywords/chemokine-system","display_name":"chemokine system","score":0.7009999752044678},{"id":"https://openalex.org/keywords/chemokine-receptors","display_name":"chemokine receptors","score":0.8299999833106995},{"id":"https://openalex.org/keywords/cxcl12","display_name":"CXCL12","score":0.8100000023841858},{"id":"https://openalex.org/keywords/cx3cl1","display_name":"fractalkine","score":0.7760000228881836},{"id":"https://openalex.org/keywords/cxcr4","display_name":"CXCR4","score":0.875},{"id":"https://openalex.org/keywords/ackr3","display_name":"CXCR7","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cx3cr1","display_name":"CX3CR1","score":0.7979999780654907},{"id":"https://openalex.org/keywords/prenatal-stress","display_name":"prenatal stress","score":0.7979999780654907},{"id":"https://openalex.org/keywords/tianeptine","display_name":"tianeptine","score":0.7940000295639038},{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":1.0},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.6610000133514404},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":0.847000002861023},{"id":"https://openalex.org/keywords/frontal-cortex","display_name":"frontal cortex","score":0.9950000047683716},{"id":"https://openalex.org/keywords/tgf-beta-signaling","display_name":"TGF-beta signaling","score":0.9369999766349792},{"id":"https://openalex.org/keywords/anxiety-like-behavior","display_name":"anxiety-like behavior","score":0.6809999942779541},{"id":"https://openalex.org/keywords/rat-offspring","display_name":"rat offspring","score":0.45500001311302185},{"id":"https://openalex.org/keywords/chronic-antidepressant-treatment","display_name":"chronic antidepressant treatment","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C2776903192","wikidata":"https://www.wikidata.org/wiki/Q424260","display_name":"Tianeptine","level":4,"score":0.9257714152336121},{"id":"https://openalex.org/C31179232","wikidata":"https://www.wikidata.org/wiki/Q14911549","display_name":"CX3CR1","level":5,"score":0.6889793872833252},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.6230989694595337},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5980923771858215},{"id":"https://openalex.org/C2776443723","wikidata":"https://www.wikidata.org/wiki/Q7240529","display_name":"Prenatal stress","level":4,"score":0.5233991742134094},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.5182080864906311},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42891186475753784},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41284313797950745},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4046124517917633},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3855133652687073},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.36934685707092285},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3288854956626892},{"id":"https://openalex.org/C112672928","wikidata":"https://www.wikidata.org/wiki/Q239526","display_name":"Offspring","level":3,"score":0.3120536208152771},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.2790294885635376},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.23910826444625854},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19419777393341064},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C2779234561","wikidata":"https://www.wikidata.org/wiki/Q11995","display_name":"Pregnancy","level":2,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fphar.2017.00779","doi":"https://doi.org/10.3389/fphar.2017.00779","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2017.00779","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2017.00779/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4606768","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5671972","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5671972","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5671972/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:29163165","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29163165","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:49a6264aa5374085862d0b90861d6ea3","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/49a6264aa5374085862d0b90861d6ea3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 8 (2017)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2017.00779","doi":"https://doi.org/10.3389/fphar.2017.00779","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2017.00779","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2017.00779/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322511","display_name":"Narodowe Centrum Nauki","ror":"https://ror.org/03ha2q922"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2765520397.pdf","grobid_xml":"https://content.openalex.org/works/W2765520397.grobid-xml"},"referenced_works_count":83,"referenced_works":["https://openalex.org/W170942893","https://openalex.org/W293382631","https://openalex.org/W1537407495","https://openalex.org/W1576427485","https://openalex.org/W1589321720","https://openalex.org/W1602000691","https://openalex.org/W1874586944","https://openalex.org/W1905242322","https://openalex.org/W1905269802","https://openalex.org/W1934930440","https://openalex.org/W1936190307","https://openalex.org/W1941997998","https://openalex.org/W1964927867","https://openalex.org/W1967696404","https://openalex.org/W1968952693","https://openalex.org/W1973041420","https://openalex.org/W1973045008","https://openalex.org/W1973386992","https://openalex.org/W1978615506","https://openalex.org/W1980132630","https://openalex.org/W1980789245","https://openalex.org/W1982479748","https://openalex.org/W1984075660","https://openalex.org/W1985005182","https://openalex.org/W1985438873","https://openalex.org/W1991854730","https://openalex.org/W1997361683","https://openalex.org/W1998520631","https://openalex.org/W1999080838","https://openalex.org/W2003982930","https://openalex.org/W2004641904","https://openalex.org/W2019640842","https://openalex.org/W2025778025","https://openalex.org/W2027098640","https://openalex.org/W2032693714","https://openalex.org/W2036586619","https://openalex.org/W2041561931","https://openalex.org/W2043465498","https://openalex.org/W2061809825","https://openalex.org/W2061859660","https://openalex.org/W2065096110","https://openalex.org/W2068080380","https://openalex.org/W2068376754","https://openalex.org/W2074306506","https://openalex.org/W2074349137","https://openalex.org/W2076547272","https://openalex.org/W2081558146","https://openalex.org/W2086692663","https://openalex.org/W2087771052","https://openalex.org/W2094716466","https://openalex.org/W2106623141","https://openalex.org/W2108904800","https://openalex.org/W2113107925","https://openalex.org/W2121393149","https://openalex.org/W2122948232","https://openalex.org/W2127278809","https://openalex.org/W2130637974","https://openalex.org/W2135757180","https://openalex.org/W2136525373","https://openalex.org/W2139530080","https://openalex.org/W2141860100","https://openalex.org/W2149069297","https://openalex.org/W2153044787","https://openalex.org/W2155115840","https://openalex.org/W2157400052","https://openalex.org/W2159822434","https://openalex.org/W2180422477","https://openalex.org/W2206933179","https://openalex.org/W2243134555","https://openalex.org/W2277028585","https://openalex.org/W2288409538","https://openalex.org/W2289753514","https://openalex.org/W2314124374","https://openalex.org/W2398210711","https://openalex.org/W2411818373","https://openalex.org/W2489232577","https://openalex.org/W2530849783","https://openalex.org/W2558574008","https://openalex.org/W2571156550","https://openalex.org/W2580929144","https://openalex.org/W2604463267","https://openalex.org/W4297022993","https://openalex.org/W6678432188"],"related_works":["https://openalex.org/W2908045260","https://openalex.org/W2943667280","https://openalex.org/W2154085228","https://openalex.org/W1973041420","https://openalex.org/W2162145283","https://openalex.org/W2765484555","https://openalex.org/W2972024266","https://openalex.org/W2804908862","https://openalex.org/W2085750167","https://openalex.org/W4240194812"],"abstract_inverted_index":{"An":[0],"increasing":[1],"number":[2],"of":[3,17,23,30,46,49,70,102,122,187,213,260,291,308],"studies":[4,343],"indicate":[5],"that":[6,140,298],"the":[7,12,18,21,24,28,44,47,54,62,74,89,97,103,114,120,126,162,185,197,228,254,265,286,330,333,346],"chemokine":[8,25,56,58],"system":[9,16,26],"may":[10,320],"be":[11,321],"third":[13],"major":[14],"communication":[15],"brain.":[19],"Therefore,":[20],"role":[22],"in":[27,96,113,148,169,178,196,218,224,231,236,250,264,285,317],"development":[29],"brain":[31,55,200,268,282],"disorders,":[32],"including":[33],"depression,":[34],"has":[35],"been":[36],"recently":[37],"proposed.":[38],"However,":[39],"little":[40],"is":[41],"known":[42],"about":[43],"impact":[45,121],"administration":[48,212],"various":[50,208],"antidepressant":[51,157,325],"drugs":[52,217],"on":[53,73,125,332],"-":[57],"receptor":[59,134,312],"axis.":[60],"In":[61,328],"present":[63],"study,":[64],"we":[65,160],"used":[66],"an":[67],"animal":[68,289],"model":[69,290],"depression":[71],"based":[72],"prenatal":[75,92,141,194,257,287,301],"stress":[76,93,142,195,258],"procedure.":[77],"We":[78,138],"determined":[79],"whether":[80],"chronic":[81,156,211,273,324],"treatment":[82],"with":[83,207],"tianeptine,":[84],"venlafaxine,":[85],"or":[86],"fluoxetine":[87,239,244,277],"influenced":[88],"evoked":[90],"by":[91,155,193,210,256,272,323],"procedure":[94],"changes":[95,204,307],"mRNA":[98],"and":[99,110,116,145,171,189,222,245,262,275,310,313,335,338],"protein":[100],"levels":[101,186,259],"homeostatic":[104],"chemokines,":[105],"CXCL12":[106,164,229,309,334],"(SDF-1\u03b1),":[107],"CX3CL1":[108,188,261],"(fractalkine)":[109],"their":[111,311,336],"receptors,":[112],"hippocampus":[115,170,237],"frontal":[117,172,179,225,251],"cortex.":[118,173,252],"Moreover,":[119,235],"mentioned":[123,203],"antidepressants":[124],"TGF-\u03b2,":[127],"a":[128],"molecular":[129],"pathway":[130],"related":[131],"to":[132,344],"fractalkine":[133],"(CX3CR1),":[135],"was":[136,176],"explored.":[137],"found":[139],"caused":[143],"anxiety":[144],"depressive-like":[146],"disturbances":[147,304],"adult":[149],"offspring":[150],"rats,":[151],"which":[152],"were":[153,191,205,270],"normalized":[154,206,227,271,322],"treatment.":[158,327],"Furthermore,":[159,184],"showed":[161],"stress-evoked":[163],"upregulation":[165],"while":[166,220,243],"CXCR4":[167,241,337],"downregulation":[168],"CXCR7":[174,248,339],"expression":[175,319],"enhanced":[177,240],"cortex":[180,226],"but":[181,305],"not":[182,299],"hippocampus.":[183],"CX3CR1":[190,263],"diminished":[192,247,255],"both":[198,266],"examined":[199,267],"areas.":[201],"The":[202],"potency":[209],"tested":[214],"antidepressants.":[215],"All":[216],"hippocampus,":[219],"tianeptine":[221,246,274],"venlafaxine":[223],"level":[230,249],"prenatally":[232],"stressed":[233],"offspring.":[234],"only":[238,300],"level,":[242],"Additionally,":[253],"areas":[269],"partially":[276],"administration.":[278],"Tianeptine":[279],"modulate":[280],"also":[281,306],"TGF-\u03b2":[283],"signaling":[284],"stress-induced":[288,302],"depression.":[292],"Our":[293],"results":[294],"provide":[295],"new":[296],"evidence":[297],"behavioral":[303],"at":[314],"less":[315],"extend":[316],"CX3CL1-CX3CR1":[318],"drug":[326],"particular,":[329],"effect":[331],"receptors":[340],"requires":[341],"additional":[342],"elucidate":[345],"possible":[347],"biological":[348],"consequences.":[349]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2765520397","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-11-10T00:00:00"}
